Source: Annual Congress 2004 - Improvements in delivery of inhaled agents
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Verbanck, D. Schuermans, M. Paiva, W. Vincken (Brussels, Belgium). Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol. Eur Respir J 2004; 24: Suppl. 48, 3571

Member's Comments

No comment yet.

Related content which might interest you: The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 Diverging airway inflammatory responses to diesel exhaust exposure in healthy and asthmatic subjects with and without inhaled corticosteroid treatment Source: Eur Respir J 2002; 20: Suppl. 38, 22s Year: 2002 Increased asthma medication use in association with ambient fine and ultrafine particles Source: Eur Respir J 2002; 20: 691-702 Year: 2002 The effects of inhaled acid aerosol on lung function of asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 497s Year: 2003 Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017 Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004 Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 40s Year: 2001 Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 The effect of inhaled corticosteroids on airway hyperresponsiveness to mannitol in patients with Type 2 low asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation: is this phenomenon airway remodeling? Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Effect of inhaled salmeterol or fluticasone on organic dust induced bronchial hyperreactivity Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002 Mycobiota of the pharynx in patients with persistent bronchial asthma who constantly applying the inhaled corticosteroids Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Assessing regional airways responses to inhaled bronchodilators in asthmatics Source: Annual Congress 2010 - Airways mechanics in different applications Year: 2010 Assessing small airways dysfunction in asthma, asthma remission and healthy controls using particles in exhaled air Source: ERJ Open Res, 5 (4) 00202-2019; 10.1183/23120541.00202-2019 Year: 2019